stakeholder intelligence

The rise of GLP-1s has fractured the patient advocacy landscape, creating new risks and opportunities for pharma. This case study analyzes the key advocacy archetypes shaping GLP-1 access policy and explains why dynamic, AI-driven intelligence is now essential.

Internal echo chambers create strategic blind spots that can derail even the most well-planned advocacy strategy. Learn why external validation is critical for success and how an external intelligence platform provides the continuous reality check needed to stay aligned, mitigate risks, and seize opportunities.

Discover why traditional stakeholder matrix mapping is a dangerously outdated tool for navigating the complex world of EU pharmaceutical policy. Learn how its static nature creates blind spots and why a shift to dynamic, AI-powered stakeholder intelligence is essential for success.